HK Stock MarketDetailed Quotes

01513 LIVZON PHARMA

Watchlist
  • 27.500
  • +0.100+0.36%
Not Open Dec 30 16:08 CST
25.06BMarket Cap11.16P/E (TTM)

LIVZON PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Cash flow from operating activities
Earning before tax
----
15.38%1.35B
----
-2.96%1.9B
----
5.06%1.17B
----
0.18%1.96B
----
-5.28%1.12B
Profit adjustment
Investment loss (gain)
----
68.30%-15.57M
----
-40.14%-61.82M
----
-34.08%-49.13M
----
50.78%-44.11M
----
-4.38%-36.64M
Impairment and provisions:
----
-38.68%32.35M
----
164.17%323.1M
----
72.01%52.76M
----
90.17%122.31M
----
-17.53%30.67M
-Other impairments and provisions
----
-85.91%3.21M
----
129.72%13.07M
----
562.83%22.79M
----
-24.54%5.69M
----
-59.92%3.44M
Revaluation surplus:
----
-43.33%18.39M
----
-65.92%25.65M
----
-63.45%32.45M
----
226.89%75.27M
----
355.14%88.78M
Asset sale loss (gain):
----
-76.71%76.44K
----
119.80%170.44K
----
-35.71%328.23K
----
87.77%-860.66K
----
260.99%510.52K
-Loss (gain) on sale of property, machinery and equipment
----
-76.71%76.44K
----
119.80%170.44K
----
-35.71%328.23K
----
87.77%-860.66K
----
260.99%510.52K
Depreciation and amortization:
----
-33.79%339.81M
----
29.50%887.9M
----
92.31%513.21M
----
45.46%685.63M
----
19.12%266.86M
-Amortization of intangible assets
----
-90.55%19.95M
----
95.96%294.99M
----
1,784.86%211.16M
----
729.97%150.54M
----
34.48%11.2M
-Other depreciation and amortization
----
76.92%65.22M
----
42.84%47.58M
----
166.01%36.86M
----
27.77%33.31M
----
2.27%13.86M
Financial expense
----
7.56%48.45M
----
141.07%94.96M
----
97.51%45.05M
----
-61.65%39.39M
----
-54.14%22.81M
Change of operating capital
Inventory (increase) decrease
----
123.85%57.93M
----
32.92%-334.42M
----
-36.80%-242.89M
----
-114.90%-498.57M
----
-8,094.48%-177.55M
Accounts receivable (increase)decrease
----
2.96%-308.49M
----
170.60%466.29M
----
-95.16%-317.89M
----
0.64%-660.45M
----
80.68%-162.89M
Accounts payable increase (decrease)
----
197.25%10.49M
----
-111.18%-115.71M
----
-103.39%-10.79M
----
353.89%1.03B
----
552.56%318.62M
Special items of business
----
-126.89%-8.1M
----
2.65%65.22M
----
171.25%30.13M
----
17.31%63.54M
----
-182.92%-42.29M
Adjustment items of business operations
4.32%2.31B
28.48%1.54B
208.30%924.25M
17.52%3.18B
19.72%2.21B
-18.49%1.2B
-57.80%299.78M
46.58%2.71B
41.57%1.85B
135.40%1.47B
Net cash from operations
4.32%2.31B
24.67%1.53B
208.30%924.25M
17.18%3.25B
19.72%2.21B
-13.96%1.23B
-57.80%299.78M
45.75%2.77B
41.57%1.85B
111.34%1.43B
Cash flow from investment activities
Dividend received - investment
-81.69%12.84M
-73.77%7M
-77.77%5.83M
11.16%145.27M
9.28%70.12M
-58.18%26.68M
284.12%26.24M
32.84%130.69M
-28.00%64.17M
-0.08%63.81M
Sale of fixed assets
-94.30%420.61K
339.89%233.14K
--201.34K
388.87%14.46M
852.19%7.38M
-90.87%53K
----
-67.44%2.96M
-89.45%775.17K
-38.17%580.55K
Purchase of fixed assets
26.94%-405.24M
32.30%-270.18M
-6.29%-155.62M
12.73%-820.45M
29.83%-554.64M
32.65%-399.06M
27.24%-146.42M
28.18%-940.15M
1.99%-790.43M
-22.37%-592.48M
Acquisition of subsidiaries
----
----
----
---22.46M
---22.46M
---22.46M
---12.46M
----
----
----
Recovery of cash from investments
17.00%437.98M
7.94%404.07M
----
--471.56M
--374.33M
--374.33M
--70.03M
----
----
----
Cash on investment
-64.83%-671.91M
10.87%-363.36M
-4,873.46%-307.55M
-18.53%-473.16M
-1,243.62%-407.64M
-1,243.82%-407.69M
79.62%-6.18M
49.21%-399.18M
96.08%-30.34M
95.92%-30.34M
Other items in the investment business
93.32%-1.4M
89.60%-931.04K
-105.11%-202.36K
2.42%-23.6M
-58.97%-21.03M
-111.82%-8.95M
-34.47%3.96M
-739.05%-24.18M
-344.21%-13.23M
-192.75%-4.23M
Net cash from investment operations
-13.25%-627.32M
48.94%-223.17M
-605.48%-457.34M
42.40%-708.37M
27.97%-553.93M
22.31%-437.1M
70.33%-64.83M
34.47%-1.23B
44.00%-769.05M
46.48%-562.65M
Net cash before financing
1.33%1.68B
65.38%1.31B
98.72%466.91M
64.67%2.54B
53.72%1.66B
-8.51%790.21M
-52.22%234.96M
5,967.38%1.54B
1,686.37%1.08B
329.53%863.73M
Cash flow from financing activities
New borrowing
9.99%3B
6.88%1.98B
-37.81%642.75M
-1.51%3.66B
-19.57%2.73B
-26.34%1.86B
-38.35%1.03B
32.63%3.71B
47.33%3.4B
108.09%2.52B
Refund
-30.65%-3.04B
-72.20%-2.09B
-104.81%-1.22B
-11.44%-3.13B
10.17%-2.33B
37.31%-1.21B
55.11%-595.57M
-37.92%-2.8B
-50.58%-2.59B
-167.62%-1.93B
Dividends paid - financing
11.04%-1.64B
24.09%-711.94M
23.58%-23.82M
-19.14%-1.9B
-17.70%-1.84B
35.54%-937.86M
-84.88%-31.17M
-5.98%-1.59B
-8.07%-1.57B
-6.01%-1.45B
Absorb investment income
312.21%161.75M
324.93%156.33M
115.00%79.1M
81.15%76.53M
47.62%39.24M
63.92%36.79M
73.64%36.79M
-94.71%42.25M
-96.47%26.58M
-96.79%22.44M
Other items of the financing business
-7.89%-393.18M
4.03%-146.93M
-4.69%-132.83M
-360.70%-369.72M
-1,809.63%-364.44M
-1,215.62%-153.1M
-22,260.25%-126.89M
90.86%-80.25M
97.57%-19.08M
98.52%-11.64M
Net cash from financing operations
-8.14%-1.91B
-96.57%-805.74M
-306.71%-654.61M
-130.01%-1.66B
-133.41%-1.77B
52.20%-409.89M
-10.37%316.69M
11.61%-720.36M
15.70%-757.59M
11.63%-857.43M
Effect of rate
-164.64%-21.35M
-91.02%2.87M
97.10%-690.2K
-83.95%20.04M
-74.95%33.03M
-50.12%31.98M
-147.55%-23.82M
436.17%124.89M
812.83%131.85M
390.63%64.1M
Net Cash
-110.93%-231.66M
31.76%501.12M
-134.03%-187.7M
7.45%883.68M
-134.18%-109.83M
5,932.87%380.31M
-34.73%551.64M
204.16%822.45M
133.24%321.28M
100.47%6.3M
Begining period cash
8.97%10.98B
8.97%10.98B
8.97%10.98B
10.38%10.07B
10.38%10.07B
10.38%10.07B
10.38%10.07B
-8.31%9.13B
-8.31%9.13B
-8.31%9.13B
Cash at the end
7.28%10.72B
9.49%11.48B
1.77%10.79B
8.97%10.98B
4.36%10B
14.02%10.48B
6.42%10.6B
10.38%10.07B
6.82%9.58B
7.13%9.2B
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Cash flow from operating activities
Earning before tax ----15.38%1.35B-----2.96%1.9B----5.06%1.17B----0.18%1.96B-----5.28%1.12B
Profit adjustment
Investment loss (gain) ----68.30%-15.57M-----40.14%-61.82M-----34.08%-49.13M----50.78%-44.11M-----4.38%-36.64M
Impairment and provisions: -----38.68%32.35M----164.17%323.1M----72.01%52.76M----90.17%122.31M-----17.53%30.67M
-Other impairments and provisions -----85.91%3.21M----129.72%13.07M----562.83%22.79M-----24.54%5.69M-----59.92%3.44M
Revaluation surplus: -----43.33%18.39M-----65.92%25.65M-----63.45%32.45M----226.89%75.27M----355.14%88.78M
Asset sale loss (gain): -----76.71%76.44K----119.80%170.44K-----35.71%328.23K----87.77%-860.66K----260.99%510.52K
-Loss (gain) on sale of property, machinery and equipment -----76.71%76.44K----119.80%170.44K-----35.71%328.23K----87.77%-860.66K----260.99%510.52K
Depreciation and amortization: -----33.79%339.81M----29.50%887.9M----92.31%513.21M----45.46%685.63M----19.12%266.86M
-Amortization of intangible assets -----90.55%19.95M----95.96%294.99M----1,784.86%211.16M----729.97%150.54M----34.48%11.2M
-Other depreciation and amortization ----76.92%65.22M----42.84%47.58M----166.01%36.86M----27.77%33.31M----2.27%13.86M
Financial expense ----7.56%48.45M----141.07%94.96M----97.51%45.05M-----61.65%39.39M-----54.14%22.81M
Change of operating capital
Inventory (increase) decrease ----123.85%57.93M----32.92%-334.42M-----36.80%-242.89M-----114.90%-498.57M-----8,094.48%-177.55M
Accounts receivable (increase)decrease ----2.96%-308.49M----170.60%466.29M-----95.16%-317.89M----0.64%-660.45M----80.68%-162.89M
Accounts payable increase (decrease) ----197.25%10.49M-----111.18%-115.71M-----103.39%-10.79M----353.89%1.03B----552.56%318.62M
Special items of business -----126.89%-8.1M----2.65%65.22M----171.25%30.13M----17.31%63.54M-----182.92%-42.29M
Adjustment items of business operations 4.32%2.31B28.48%1.54B208.30%924.25M17.52%3.18B19.72%2.21B-18.49%1.2B-57.80%299.78M46.58%2.71B41.57%1.85B135.40%1.47B
Net cash from operations 4.32%2.31B24.67%1.53B208.30%924.25M17.18%3.25B19.72%2.21B-13.96%1.23B-57.80%299.78M45.75%2.77B41.57%1.85B111.34%1.43B
Cash flow from investment activities
Dividend received - investment -81.69%12.84M-73.77%7M-77.77%5.83M11.16%145.27M9.28%70.12M-58.18%26.68M284.12%26.24M32.84%130.69M-28.00%64.17M-0.08%63.81M
Sale of fixed assets -94.30%420.61K339.89%233.14K--201.34K388.87%14.46M852.19%7.38M-90.87%53K-----67.44%2.96M-89.45%775.17K-38.17%580.55K
Purchase of fixed assets 26.94%-405.24M32.30%-270.18M-6.29%-155.62M12.73%-820.45M29.83%-554.64M32.65%-399.06M27.24%-146.42M28.18%-940.15M1.99%-790.43M-22.37%-592.48M
Acquisition of subsidiaries ---------------22.46M---22.46M---22.46M---12.46M------------
Recovery of cash from investments 17.00%437.98M7.94%404.07M------471.56M--374.33M--374.33M--70.03M------------
Cash on investment -64.83%-671.91M10.87%-363.36M-4,873.46%-307.55M-18.53%-473.16M-1,243.62%-407.64M-1,243.82%-407.69M79.62%-6.18M49.21%-399.18M96.08%-30.34M95.92%-30.34M
Other items in the investment business 93.32%-1.4M89.60%-931.04K-105.11%-202.36K2.42%-23.6M-58.97%-21.03M-111.82%-8.95M-34.47%3.96M-739.05%-24.18M-344.21%-13.23M-192.75%-4.23M
Net cash from investment operations -13.25%-627.32M48.94%-223.17M-605.48%-457.34M42.40%-708.37M27.97%-553.93M22.31%-437.1M70.33%-64.83M34.47%-1.23B44.00%-769.05M46.48%-562.65M
Net cash before financing 1.33%1.68B65.38%1.31B98.72%466.91M64.67%2.54B53.72%1.66B-8.51%790.21M-52.22%234.96M5,967.38%1.54B1,686.37%1.08B329.53%863.73M
Cash flow from financing activities
New borrowing 9.99%3B6.88%1.98B-37.81%642.75M-1.51%3.66B-19.57%2.73B-26.34%1.86B-38.35%1.03B32.63%3.71B47.33%3.4B108.09%2.52B
Refund -30.65%-3.04B-72.20%-2.09B-104.81%-1.22B-11.44%-3.13B10.17%-2.33B37.31%-1.21B55.11%-595.57M-37.92%-2.8B-50.58%-2.59B-167.62%-1.93B
Dividends paid - financing 11.04%-1.64B24.09%-711.94M23.58%-23.82M-19.14%-1.9B-17.70%-1.84B35.54%-937.86M-84.88%-31.17M-5.98%-1.59B-8.07%-1.57B-6.01%-1.45B
Absorb investment income 312.21%161.75M324.93%156.33M115.00%79.1M81.15%76.53M47.62%39.24M63.92%36.79M73.64%36.79M-94.71%42.25M-96.47%26.58M-96.79%22.44M
Other items of the financing business -7.89%-393.18M4.03%-146.93M-4.69%-132.83M-360.70%-369.72M-1,809.63%-364.44M-1,215.62%-153.1M-22,260.25%-126.89M90.86%-80.25M97.57%-19.08M98.52%-11.64M
Net cash from financing operations -8.14%-1.91B-96.57%-805.74M-306.71%-654.61M-130.01%-1.66B-133.41%-1.77B52.20%-409.89M-10.37%316.69M11.61%-720.36M15.70%-757.59M11.63%-857.43M
Effect of rate -164.64%-21.35M-91.02%2.87M97.10%-690.2K-83.95%20.04M-74.95%33.03M-50.12%31.98M-147.55%-23.82M436.17%124.89M812.83%131.85M390.63%64.1M
Net Cash -110.93%-231.66M31.76%501.12M-134.03%-187.7M7.45%883.68M-134.18%-109.83M5,932.87%380.31M-34.73%551.64M204.16%822.45M133.24%321.28M100.47%6.3M
Begining period cash 8.97%10.98B8.97%10.98B8.97%10.98B10.38%10.07B10.38%10.07B10.38%10.07B10.38%10.07B-8.31%9.13B-8.31%9.13B-8.31%9.13B
Cash at the end 7.28%10.72B9.49%11.48B1.77%10.79B8.97%10.98B4.36%10B14.02%10.48B6.42%10.6B10.38%10.07B6.82%9.58B7.13%9.2B
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data